New CDC awards for innovative research to combat antibiotic resistance
CDC Awards More Institutions than Ever Before to Explore Knowledge Gaps Using a One Health Approach
CDC awarded more than $15 million to 41 private and academic investigators to pilot innovative solutions to protect people from antibiotic resistance. The awards are among the most diverse the agency has ever awarded and span the One Health continuum, covering topics that relate to humans, animals, and the environment.
For the third year in a row, CDC is collaborating with researchers domestically and internationally to better understand antibiotic resistance. Antibiotic resistance causes deadly infections in humans and animals, threatens every country, and jeopardizes modern healthcare, veterinary, and agriculture industries.
For example, CDC and investigators will:
Analyze antibiotic-resistant germs and genes in water systems and the environment, and their contribution to human infections
Develop and analyze new diagnostic, sequencing, and metagenomics tools for antibiotic resistance detection and improved antibiotic use
Study domestic and international transmission, colonization, and prevention of antibiotic-resistant germs
Investigate the human microbiome and how it relates to antibiotic resistance
Improve antibiotic stewardship
Insights gained will inform CDC’s efforts to protect people. These pilot projects will help better detect antibiotic resistance, help advise treatment and prevention recommendations, and prevent the spread of antibiotic-resistant infections.
These awards, made through a broad agency announcement (BAA), are part of the Antibiotic Resistance Solutions Initiative and are intended to grow the agency’s innovative approaches to combat antibiotic resistance. In fiscal years 2016-2018, CDC’s Antibiotic Resistance Solutions Initiative awarded more than $39 million to BAA awardees to fight antibiotic resistance.
This year’s BAA awardees include:
California Department Of Public Health
Cleveland VA Medical Center
Henry Ford Health System
ImpeDx Diagnostics Inc.
Iowa State University
Johns Hopkins Bayview Medical Center
Johns Hopkins University
Massachusetts Department of Public Health
Rush University Medical Center
Texas Tech University
The Children’s Hospital of Philadelphia
The Ohio State University
Universidad del Desarrollo
University of Alabama at Birmingham
University of Arizona
University of California Irvine
University of Chicago
University of Georgia
University of Leeds
University of Maryland, Baltimore
University of Michigan
University of Nebraska
University of Oxford
University of Pennsylvania
University of South Carolina
University of Virginia
Washington University in St. Louis